×
Merck Cash on Hand 2010-2024 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Merck cash on hand for the quarter ending September 30, 2024 was
$14.593B
, a
66.34% increase
year-over-year.
Merck cash on hand for 2023 was
$7.093B
, a
46.23% decline
from 2022.
Merck cash on hand for 2022 was
$13.192B
, a
62.94% increase
from 2021.
Merck cash on hand for 2021 was
$8.096B
, a
0.57% increase
from 2020.
View More
Merck Cash on Hand 2010-2024 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Merck cash on hand for 2023 was
$7.093B
, a
46.23% decline
from 2022.
Merck cash on hand for 2022 was
$13.192B
, a
62.94% increase
from 2021.
Merck cash on hand for 2021 was
$8.096B
, a
0.57% increase
from 2020.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$710.1B
Novo Nordisk (NVO)
$471.5B
Johnson & Johnson (JNJ)
$373.6B
AbbVie (ABBV)
$312.7B
Novartis AG (NVS)
$213.1B
AstraZeneca (AZN)
$203.5B
Pfizer (PFE)
$145.4B
Sanofi (SNY)
$122.5B
Innoviva (INVA)
$1.2B